Delivery Order SPE2DB24D2100-SPE2DB25FBBRS
Award Date
1/13/25
Potential Completion Date
2/4/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product, with a completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XERMELO 250 MG TABLET 84S. The contract is a Firm Fixed Price contract with a ceiling value of $5,526.76 and a period of performance ending on July 7, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor and there are no major subcontractors listed. The contract is...
This federal contract award is a Delivery Order (DO) valued at $11,991.67 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The DO is for the procurement of XELJANZ XR 11 MG TABLET UU 30S, with an ultimate completion date of May 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an award value of $4,415.81 and a completion date of February 4, 2025. It is a Firm Fixed Price Delivery Order contract for the supply of the pharmaceutical product XELJANZ XR 11 MG TABLET, which is used for various medical treatments. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DO, valued at $3,437.93, is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has a completion date of February 13, 2024. This award is part of Amerisourcebergen's broader pharmaceutical and medical supply contracts with the federal...
This federal contract award is a delivery order with a firm fixed price of $1,873.25 and a ceiling value of $1,873.25. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through June 6, 2025. The contract is not set-aside and is an open competition...
This federal contract award, valued at $6,966.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the drug XELJANZ XR 11 MG TABLET UU 30S, with an ultimate completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order for XELJANZ 5 MG TABLET UU 60S, a pharmaceutical product, with a firm fixed price ceiling value of $4,262.72 and an ultimate completion date of June 13, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide a range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The award has a ceiling value of $4,281.32 and an ultimate completion date of December 28, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract covers the delivery of various medications, including XELJANZ XR 11 MG TABLET, as well as other pharmaceutical products,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $40,741.97 firm fixed-price delivery order from the Defense Logistics Agency (DLA). The contract covers the supply of 4564545045 ! XELJANZ XR 11 MG TABLET UU 30S, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...